Healthcare-associated Stenotrophomonas maltophilia infections in the United States, 2018–2022
Background: Stenotrophomonas maltophilia is an important cause of opportunistic healthcare-associated infections (HAIs) in critically ill patients and is difficult to treat due to intrinsic resistance to multiple antibiotic classes. During the COVID-19 pandemic, the CDC received anecdotal reports of...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Cambridge University Press
2023-06-01
|
| Series: | Antimicrobial Stewardship & Healthcare Epidemiology |
| Online Access: | https://www.cambridge.org/core/product/identifier/S2732494X23003522/type/journal_article |
| _version_ | 1797670840066637824 |
|---|---|
| author | Amelia Keaton Lucy Fike Kevin Spicer Alexander Kallen Kiran Perkins |
| author_facet | Amelia Keaton Lucy Fike Kevin Spicer Alexander Kallen Kiran Perkins |
| author_sort | Amelia Keaton |
| collection | DOAJ |
| description | Background: Stenotrophomonas maltophilia is an important cause of opportunistic healthcare-associated infections (HAIs) in critically ill patients and is difficult to treat due to intrinsic resistance to multiple antibiotic classes. During the COVID-19 pandemic, the CDC received anecdotal reports of increases in S. maltophilia respiratory infections. To further investigate these reports, we used a national electronic healthcare database to evaluate changes in S. maltophilia during the pandemic. Methods: Using the PINC-AI healthcare data (Premier Inc, Charlotte, NC) we identified all potential HAIs by calculating the total number of unique patients hospitalized during January 1, 2018, through December 31, 2021, who had any organism isolated on clinical culture obtained >3 days after admission. We calculated the proportion of patients with S. maltophilia detected in culture and stratified them by specimen source. To determine whether COVID-19 diagnosis influenced the proportion of patients diagnosed with S. maltophilia respiratory infections during the pandemic (January 1, 2020–December 31, 2021), we calculated the proportion of patients with S. maltophilia detected among those with any bacterial pathogen isolated from a respiratory culture >3 days after hospitalization. We stratified these results by presence or absence of concurrent COVID-19 diagnosis. Pearson χ2 test was used to test for differences where appropriate. Results: Among hospitalized patients with any organism isolated from a clinical culture, the proportion with S. maltophilia detected was higher in 2021 (n = 2,554 of 118,029, 2.2%) than in 2018 (n = 2,063 of 155,624, 1.3%) p 3 days after hospital admission from 2018 to 2021. Most patient isolates were from respiratory specimens. A concurrent diagnosis of COVID-19 did not appear to increase the likelihood of respiratory S. maltophilia detection. The increases in S. maltophilia during the pandemic might be explained by challenges inherent to caring for increased numbers of higher-acuity patients during this time, including staffing shortages and changes to infection prevention practices. Additional exploration of these data, as well as data from other sources and from additional years, may help to elucidate this issue more fully. |
| first_indexed | 2024-03-11T21:05:28Z |
| format | Article |
| id | doaj.art-335d569784db4cb6a978ce28da8c7e66 |
| institution | Directory Open Access Journal |
| issn | 2732-494X |
| language | English |
| last_indexed | 2024-03-11T21:05:28Z |
| publishDate | 2023-06-01 |
| publisher | Cambridge University Press |
| record_format | Article |
| series | Antimicrobial Stewardship & Healthcare Epidemiology |
| spelling | doaj.art-335d569784db4cb6a978ce28da8c7e662023-09-29T12:56:57ZengCambridge University PressAntimicrobial Stewardship & Healthcare Epidemiology2732-494X2023-06-013s89s8910.1017/ash.2023.352Healthcare-associated Stenotrophomonas maltophilia infections in the United States, 2018–2022Amelia KeatonLucy FikeKevin SpicerAlexander KallenKiran PerkinsBackground: Stenotrophomonas maltophilia is an important cause of opportunistic healthcare-associated infections (HAIs) in critically ill patients and is difficult to treat due to intrinsic resistance to multiple antibiotic classes. During the COVID-19 pandemic, the CDC received anecdotal reports of increases in S. maltophilia respiratory infections. To further investigate these reports, we used a national electronic healthcare database to evaluate changes in S. maltophilia during the pandemic. Methods: Using the PINC-AI healthcare data (Premier Inc, Charlotte, NC) we identified all potential HAIs by calculating the total number of unique patients hospitalized during January 1, 2018, through December 31, 2021, who had any organism isolated on clinical culture obtained >3 days after admission. We calculated the proportion of patients with S. maltophilia detected in culture and stratified them by specimen source. To determine whether COVID-19 diagnosis influenced the proportion of patients diagnosed with S. maltophilia respiratory infections during the pandemic (January 1, 2020–December 31, 2021), we calculated the proportion of patients with S. maltophilia detected among those with any bacterial pathogen isolated from a respiratory culture >3 days after hospitalization. We stratified these results by presence or absence of concurrent COVID-19 diagnosis. Pearson χ2 test was used to test for differences where appropriate. Results: Among hospitalized patients with any organism isolated from a clinical culture, the proportion with S. maltophilia detected was higher in 2021 (n = 2,554 of 118,029, 2.2%) than in 2018 (n = 2,063 of 155,624, 1.3%) p 3 days after hospital admission from 2018 to 2021. Most patient isolates were from respiratory specimens. A concurrent diagnosis of COVID-19 did not appear to increase the likelihood of respiratory S. maltophilia detection. The increases in S. maltophilia during the pandemic might be explained by challenges inherent to caring for increased numbers of higher-acuity patients during this time, including staffing shortages and changes to infection prevention practices. Additional exploration of these data, as well as data from other sources and from additional years, may help to elucidate this issue more fully.https://www.cambridge.org/core/product/identifier/S2732494X23003522/type/journal_article |
| spellingShingle | Amelia Keaton Lucy Fike Kevin Spicer Alexander Kallen Kiran Perkins Healthcare-associated Stenotrophomonas maltophilia infections in the United States, 2018–2022 Antimicrobial Stewardship & Healthcare Epidemiology |
| title | Healthcare-associated Stenotrophomonas maltophilia infections in the United States, 2018–2022 |
| title_full | Healthcare-associated Stenotrophomonas maltophilia infections in the United States, 2018–2022 |
| title_fullStr | Healthcare-associated Stenotrophomonas maltophilia infections in the United States, 2018–2022 |
| title_full_unstemmed | Healthcare-associated Stenotrophomonas maltophilia infections in the United States, 2018–2022 |
| title_short | Healthcare-associated Stenotrophomonas maltophilia infections in the United States, 2018–2022 |
| title_sort | healthcare associated stenotrophomonas maltophilia infections in the united states 2018 2022 |
| url | https://www.cambridge.org/core/product/identifier/S2732494X23003522/type/journal_article |
| work_keys_str_mv | AT ameliakeaton healthcareassociatedstenotrophomonasmaltophiliainfectionsintheunitedstates20182022 AT lucyfike healthcareassociatedstenotrophomonasmaltophiliainfectionsintheunitedstates20182022 AT kevinspicer healthcareassociatedstenotrophomonasmaltophiliainfectionsintheunitedstates20182022 AT alexanderkallen healthcareassociatedstenotrophomonasmaltophiliainfectionsintheunitedstates20182022 AT kiranperkins healthcareassociatedstenotrophomonasmaltophiliainfectionsintheunitedstates20182022 |